US EditionMainz Biomed announces technology partnership with EDX Medical Group - Mainz Biomed
Summary by Mainz Biomed
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
BERKELEY, USA and MAINZ, Germany – April 29, 2025 – Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular diagnostics company specializing in early cancer detection, announced a technology partnership with the UK-based EDX Medical Group plc (AQSE: EDX). EDX Medical develops innovative digital diagnostic products and services to support personalized treatments for cancer, cardiovascular, and infectious diseases. Under the…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
